Neurology® Podcast

The May 2025 recall features four previously posted episodes on myasthenia gravis. The first episode has Dr. Fredrik Piehl discussing rituximab for new-onset generalized MG. In the second episode, Dr. Vera Bril explores the potential use of immunoglobulin as a corticosteroid-sparing agent in MG patients. The third episode features Dr. Ali A. Habib discussing trends in hospital admissions and in-hospital mortality for adult MG patients. The series concludes with Dr. Jennifer Morganroth addressing the increase in thymectomy procedures post-MGTX trial, disparities in access to these surgeries among different demographic groups, and the rise of minimally invasive surgical techniques. Podcast links: Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis  Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis Hospitalizations and Mortality from MG Hospitalizations and Mortality From Myasthenia Gravis Trends and Disparities in the Utilization of Thymectomy for MG in the US Article links: Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis Hospitalizations and Mortality From Myasthenia Gravis Trends and Disparities in the Utilization of Thymectomy for Myasthenia Gravis in the United States Disclosures can be found at Neurology.org.

Dr. Greg Cooper talks with Dr. Joseph Therriault about the use of plasma biomarkers in diagnosing Alzheimer disease, emphasizing the importance of interpreting these biomarkers within the clinical context of the patient.  Read the related article in Nature. Disclosures can be found at Neurology.org. 

Dr. Halley Alexander talks with Dr. Paula Marques about sex differences in genetically determined epilepsies. Read the related article in Neurology® Genetics. Disclosures can be found at Neurology.org.  

Dr. Tesha Monteith talks with Dr. Peter Goadsby about advances in headache science and classification.  Read the editorial about ICHD-4. Disclosures can be found at Neurology.org. 

Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis. Read the related article on Tolebrutinib versus Teriflunomide in The New England Journal of Medicine. Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in The New England Journal of Medicine. Disclosures can be found at Neurology.org. 

Dr. Jeff Ratliff talks with Dr. Harry W. Sutherland about diversity in teaching methods, the balance between clinical responsibilities and educational opportunities, and innovative models like the academic half day. Read the related article in Neurology® Education. Disclosures can be found at Neurology.org. 

Dr. Jessica Ailani talks with Dr. Richard B. Lipton about the significance of recognizing prodromal symptoms, the findings from the PRODROME trial, and the implications for clinical practice.  Read the related article with Neurology® Clinical Practice. Disclosures can be found at Neurology.org.   

Prof. Jon Stone talks with Dr. Laura Strom and Meagan Watson about changes in total emergency department and inpatient visits and costs before and after referral to a specialized, comprehensive functional seizure treatment clinic. Read the related article with Neurology® Clinical Practice. Disclosures can be found at Neurology.org.   

Neurology® Open Access has officially launched.  In this episode, Dr. Jeff Ratliff and NOA Editor, Dr. Amy C. Kunchok share insights about Neurology® Open Access (NOA). Read more about Neurology® Open Access in this editorial, and visit the Neurology® Open Access website.   Disclosures can be found at Neurology.org.

Dr. Jeff Ratliff talks with Dr. Mehari Gebreyohanns, the recipient of the 2025 Ted Burns Humanism in Neurology Award, about his journey into stroke care, the BORNE initiative, and the challenges faced in global neurology. Disclosures can be found at Neurology.org.